Ποια είναι η τιμή για Synmosa Biopharma Corporation (4114)

Η τιμή για Synmosa Biopharma Corporation (4114) είναι $0.94761103

Ποια είναι η κεφαλαιοποίηση αγοράς για Synmosa Biopharma Corporation (4114)

Η κεφαλαιοποίηση αγοράς για Synmosa Biopharma Corporation (4114) είναι $511.40M

Synmosa Biopharma Corporation (4114) Τιμή και Κεφαλαιοποίηση Αγοράς

Synmosa Biopharma Corporation, established in Taipei, Taiwan, in 1980, operates as a dedicated specialty pharmaceutical enterprise. The company manages the entire lifecycle of pharmaceutical and healthcare products, from research and development to manufacturing, marketing, and distribution, primarily serving the Taiwanese market under its proprietary Synmosa brand. Its diverse product portfolio addresses key therapeutic categories, including cardiovascular health, respiratory conditions, urology, sex hormone treatments, and oncology. These offerings are available in various formats such as effervescent tablets, granules, nasal sprays, metered-dose inhalers, hormonal preparations, and other specialized forms. Beyond its proprietary products, Synmosa also extends its expertise through contract manufacturing services. The company maintains a significant international presence, exporting its goods to numerous countries including South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nicaragua.

Η τιμή για 4114	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$9,792.93 $511.40M	NVDA	$5.285T	+1,033,333.64%
$8,652.90 $511.40M	AAPL	$4.670T	+913,027.46%
$7,561.14 $511.40M	GOOG	$4.081T	+797,816.09%
$7,001.53 $511.40M	MSFT	$3.779T	+738,760.97%
$5,228.49 $511.40M	AMZN	$2.822T	+551,654.44%

Η τιμή για 4114

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$9,792.93 $511.40M